Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' is now displayed at the top of the page. The notice about government funding and the previous 'Revision: v3.4.1' text were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page version updated to v3.4.1 (replacing v3.4.0); no core study content changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary display option and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with Revision set to v3.4.0. The previous labels ('Last Update Submitted that met QC Criteria' and 'No FEAR Act data') and v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, which appears to be an internal versioning update with no changes to the study content displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates add 'Revision: v3.3.3' and remove 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check91 days agoChange DetectedPublications notes updated to clarify that entries are provided voluntarily and may pertain to study results, are auto-filled from PubMed and may not be about the study, and the revision is now v3.3.2 (replacing the previous v3.2.0 wording).SummaryDifference0.2%

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.